04.10.2022 - NEW YORK and BERLIN, Oct. 04, 2022 (GLOBE NEWSWIRE) - atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in in the following .